Literature DB >> 6408146

Kaposi's sarcoma in homosexual men: an immunohistochemical study.

R L Modlin, F M Hofman, R A Kempf, C R Taylor, M A Conant, T H Rea.   

Abstract

A recent outbreak of disseminated Kaposi's sarcoma has been recognized in homosexual men in New York, San Francisco, and Los Angeles. Biopsy specimens of skin lesions were obtained from nine of these homosexual men in Los Angeles and San Francisco. T lymphocyte subset antigens, factor VIII-related antigen, and HLA-Dr antigen were evaluated in situ in frozen sections using immunoperoxidase technics. Factor VIII-related antigen and HLA-Dr antigen were present on tumor cells, supporting a vascular endothelial origin of this neoplasm. Langerhans cells and T lymphocytes were present in numbers similar to that of normal skin in skin specimens from seven patients with Kaposi's sarcoma with visceral dissemination, but were increased in specimens from two patients with only cutaneous involvement.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408146     DOI: 10.1016/s0190-9622(83)70067-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

Authors:  V Fiorelli; R Gendelman; F Samaniego; P D Markham; B Ensoli
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

2.  AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens.

Authors:  P A Scully; H K Steinman; C Kennedy; K Trueblood; D M Frisman; J R Voland
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium.

Authors:  J H Beckstead; G S Wood; V Fletcher
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

4.  Interferon-induced expression of class II major histocompatibility antigens in the major histocompatibility complex (MHC) class II deficiency syndrome.

Authors:  S Plaeger-Marshall; A Haas; L T Clement; J V Giorgi; I S Chen; S G Quan; R A Gatti; E R Stiehm
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

5.  The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin.

Authors:  J L Rutgers; R Wieczorek; F Bonetti; K L Kaplan; D N Posnett; A E Friedman-Kien; D M Knowles
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

6.  Initial lesions of HIV-related Kaposi's sarcoma--a histological, immunohistochemical, and ultrastructural study.

Authors:  H J Schulze; A Rütten; G Mahrle; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

7.  Lymphaticovenous differentiation in Kaposi's sarcoma. Cellular phenotypes by stage.

Authors:  M Dictor; C Andersson
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

8.  Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria.

Authors:  Samuel J Balin; Matteo Pellegrini; Eynav Klechevsky; Sohui T Won; David I Weiss; Aaron W Choi; Joshua Hakimian; Jing Lu; Maria Teresa Ochoa; Barry R Bloom; Lewis L Lanier; Steffen Stenger; Robert L Modlin
Journal:  Sci Immunol       Date:  2018-08-31

9.  Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunotherapy.

Authors:  M U Rahman; A Mazumder
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

10.  Factor-XIIIa-expressing dermal dendrocytes in Kaposi's sarcoma. A comparison between classical and immunosuppression-associated types.

Authors:  J Kanitakis; M Roca-Miralles
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.